Turn innovation into venture-ready opportunity.

A commercialisation partner for universities, research institutions, accelerators, healthcare organisations and industry.

PARTNER WITH HTLS

From research potential to commercial pathway.

Promising innovation often needs more than technology transfer alone. HTLStudio brings together company creation, leadership, capital readiness and commercial execution around one opportunity.

  • Venture thesis, governance and company formation.

  • Experienced executives placed where the venture needs them.

  • Narrative, data room, financial model and investor process.

  • Market access, partnerships and go-to-market design.

Early Opportunity Assessment.

BEFORE THE SPIN-OUT

Which innovations should become companies?

Not every promising technology should follow the same commercial path.

HTLStudio helps partners assess scientific, clinical and commercial potential before significant time and capital are committed.

A diverse group of four people having a discussion around a round black table in a modern, dark-colored room with large windows and a view of trees outside. The table features a model of a human heart, notebooks, and laptops with medical images.

Scientific potential

Strength of the underlying innovation and evidence.

Unmet need

Clinical relevance and real-world problem fit.

Market potential

Commercial opportunity, competition and adoption.

Venture feasibility

Leadership, regulatory pathway, capital requirements and scalability.

Scientists in a modern laboratory working with microscopes, computers, and scientific equipment.

FROM IP TO COMPANY

Build the venture around the innovation.

Once an opportunity is validated, HTLStudio can help structure the company required to take it forward.

  • Define the problem, opportunity and commercial proposition.

  • Structure governance, ownership and operating foundations.

  • Identify and deploy the right executives.

  • Align clinical, regulatory, technical and commercial milestones.

  • Define funding requirements and prepare for external invetment.

Two scientists in white coats working together at a laboratory table with scientific equipment, in a modern lab with large windows and dark blue walls.
LEARN MORE
Two people sitting at a dark table in a modern, dark-colored office or meeting room, engaged in conversation. There is a potted plant, a lamp, and some books in the background.

Different Partners, One Model.

WHO WE PARTNER WITH

Different institutions. One objective: progress.

A group of five scientists or medical professionals having a discussion around a table in a laboratory or research facility, with scientific diagrams on a whiteboard in the background.

Universities & Research Institutions

Transform promising research and IP into investable spin-outs.

Three business professionals in a modern office conference room looking at a laptop, two seated women and one standing man, engaged in a discussion.

Accelerators & Innovation Hubs

Add experienced healthcare operators and specialist capability to venture programmes.

Medical team discussing with patient in hospital corridor, with patient in background receiving care.

Hospitals & Healthcare Organisations

Evaluate and commercialise innovation originating from clinical environments.

A group of four professionals, three men and one woman, having a meeting in a modern office conference room with large windows. The woman is standing and showing something on a laptop to the seated colleagues, who are attentively listening and looking at the device.

Corporate & Industrial Partners

Explore new ventures, strategic collaborations and healthcare innovation opportunities.

HOW WE WORK

More then an
external adviser.

HTLStudio works alongside innovation teams from opportunity assessment through venture formation and growth.

A group of four professionals having a business meeting in a modern high-rise office with large windows overlooking a cityscape and mountains at sunset.

Embedded

We work closely with institutional and venture teams.

Specialist

The right scientific, regulatory, commercial and leadership expertise is brought in when needed.

Flexible

Support can focus on one opportunity or a broader innovation pipeline.

Outcome-driven

The objective is not another report - it is a clearer path to commercial impact.

Group of medical professionals having a meeting in a well-lit, modern hospital or clinic. Four people, including doctors and a visitor, are gathered around a round table with laptops, tablets, notebooks, and a potted plant, engaged in discussion.

BEYOND ONE VENTURE

Build stronger innovation pipelines.

  • Assess multiple technologies against defined venture criteria.

  • Structured support across a cohort or innovation portfolio.

  • Bring experienced operators into individual opportunities as required.

  • Prepare selected ventures for external capital.

  • Create clearer routes from institutional innovation to market.

THE PATHWAY

From discovery to real-world impact.

  • Identify the strongest commercial opportunities.

  • Define the venture thesis and pathway.

  • Create the company and leadership structure.

  • Prepare the venture for investment.

  • Move toward market, partnerships and scale.

Have innovation with commercial opportunity?

Bring us the research, technology and opportunity.

START A CONVERSATION